BOXED WARNING Not for treatment of obesity or weight loss; large doses may cause serious or life-threatening toxicity, especially with sympathomimetic amines.
FDA dosing
Population
Start
Target
Max
Hypothyroidism
Adults
30 mg QD (15 mg QD if long-standing myxedema/CV impairment)
60-120 mg/day
Congenital hypothyroidism
0-6 months
15-30 mg/day
Congenital hypothyroidism
6-12 months
30-45 mg/day
Congenital hypothyroidism
1-5 years
45-60 mg/day
Congenital hypothyroidism
6-12 years
60-90 mg/day
Congenital hypothyroidism
Over 12 years
Over 90 mg/day
Titration Increase by 15 mg every 2 to 3 weeks
Renal Undefined
Hepatic Undefined
Failure to respond to 180 mg/day suggests noncompliance or malabsorption
Instructions
Given orally
Individualize by indication, patient response, and lab findings
Appearance of angina is an indication for dose reduction
Advise stopping biotin supplements at least 2 days before TSH/T4 testing
Full replacement doses may be started immediately in infants with congenital hypothyroidism
Contraindications
Uncorrected adrenal cortical insufficiency
Untreated thyrotoxicosis
Cautions
Overtreatment causes hyperthyroidism/toxicity
Caution with cardiovascular disease; may precipitate angina
Additive effects with sympathomimetic amines
Adverse reactions
Adverse reactions are generally those of hyperthyroidism from overdosage (e.g., palpitations, tachycardia, tremor, weight loss, heat intolerance)